Baxter International, Inc.
One Baxter Parkway
About Baxter International, Inc.
Baxter touches millions of lives every day. Our products and services are essential building blocks of healthcare.
You’ll find Baxter’s products and therapies on nearly every floor, in every department, in almost every hospital worldwide. You’ll find us in clinics and in the home. Patients and providers rely on Baxter for lifesaving renal and medical products, including intravenous (IV) solutions, systems and administrative sets, IV infusion parenteral nutrition, perioperative care, pharmacy devices and software, acute renal care, and home and in-center dialysis.
Our mission to save and sustain lives inspires our work and our commitment to expanding access to care, providing cost-effective healthcare solutions, delivering quality products and advancing innovations for the world.
Our commitment to our mission means we are there when patients and healthcare professionals need us, during the critical moments that matter most.
CEO: José (Joe) E. Almeida
CMO: James R. Gavin III
CTO: Uma Chowdhry
CFO: Peter Hellman
FOLLOW BAXTER INTERNATIONAL:
Tweets by Baxer International
913 articles with Baxter International, Inc.
Baxter International Inc., a leading global medical products company, will host a conference call to discuss its fourth-quarter 2019 financial results on Tuesday, March 17, 2020, at 7:30 a.m. Central Time.
Baxter Launches Peri-Strips Dry With Secure Grip Technology for Reliable Staple Line Reinforcement in Surgical Procedures
Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, announced 510(k) clearance from the U.S. Food and Drug Administration for a new generation of its Peri-Strips Dry with Veritas Collagen Matrix (PSDV) product, known as PSDV with Secure Grip
Baxter International Inc., a leading global medical products company, will present at the Raymond James 41st Annual Institutional Investors Conference in Orlando, Fla. on Monday, March 2, 2020.
Baxter International Inc., a leading global medical products company, announced that its Board of Directors has declared a quarterly cash dividend of $0.22 per share of common stock.
Baxter International Inc. (NYSE:BAX), a leading global medical products company, has completed its previously announced acquisition of Seprafilm Adhesion Barrier and related assets from Sanofi for $350 million
Feb. 12, 2020 13:07 UTC Compact, portable monitor that accurately measures patient’s resting energy expenditure to help optimize nutrition therapy Technology replaces potentially inaccurate predictive equations Expected to launch in the United States at ASPEN Conference in March 2020 DEERFIELD, Ill.--( BUSINESS WIRE )-- Baxter International Inc. (NYSE: BAX), a global leader in clinical nutrition, today announced the U.S. Food and Drug Administration
Baxter and Spectral Medical Announce Exclusive Distribution Agreement for Blood Filter in U.S. and Canada
Baxter International Inc. (NYSE:BAX), a leading global medical products company, and Spectral Medical Inc. (TSX:EDT), a late stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced a distribution agreement for TORAYMYXIN™ PMX-20R (PMX), a hemoperfusion filter, and the Endotoxin Activity Assay™ (EAA), an on-market companion diagnostic tool that aids in the risk assessment of ICU patients for progression to severe sepsis
José (Joe) E. Almeida, Baxter’s chairman and chief executive officer, is scheduled to present at 9:30 a.m. Eastern Time.
Baxter Announces Preliminary Net Sales for the Fourth-Quarter and Full-Year 2019 and Announces Preliminary Full-Year 2020 Guidance
Baxter International Inc. announced preliminary net sales for the quarter and full year ended December 31, 2019, and preliminary full-year 2020 guidance for select financial metrics.
BAXTER LOSS ALERT: ROSEN LAW FIRM Reminds Baxter International Inc. Investors of Important January 24th Deadline in Securities Class Action
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Baxter International Inc. between February 21, 2019 and October 23, 2019, inclusive of the important January 24, 2020 lead plaintiff deadline in the case.
José (Joe) E. Almeida, Baxter’s chairman and chief executive officer, is scheduled to present on Monday, January 13, 2020 at 10:00 a.m. Pacific Time.
ROSEN, A HIGHLY RANKED FIRM, Announces Filing of Securities Class Action Lawsuit Against Baxter International Inc. - BAX
Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Baxter International Inc.
The agreement is the latest example of Baxter’s continued focus on acquiring products and technologies that have a strong strategic fit with the company’s leading portfolio across the hospital, including in the operating room.
Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced that the New York Stock Exchange (NYSE) notified the Company that it is not in compliance with Section 802.01E of the NYSE Listed Company Manual due to a delay in filing its Quarterly Report on Form 10-Q for the quarter ended September 30, 2019 with the Securities and Exchange Commission (SEC).
The dividend is payable on Jan. 2, 2020, to shareholders of record as of Dec. 6, 2019.
Baxter International Inc., a leading global medical products company, will present at the Evercore ISI 2nd Annual HealthCONx Conference in Boston on December 4, 2019.
Baxter International Inc., a leading global medical products company, will present at the 28th Annual Credit Suisse Healthcare Conference in Scottsdale, Ariz., on November 12, 2019.
The Company announces internal investigation of misstatements in previously reported non-operating income related to foreign exchange gains and losses
Baxter also recently named one of Working Mother’s 2019 ‘100 Best Companies’
Baxter Home Dialysis Study Associates Sharesource With 39% Reduction in Hospitalization Rates for Colombian Patients
Baxter International Inc., a global innovator in renal care, announced today new data associating the use of its automated peritoneal dialysis (APD) cyclers and the Sharesource remote patient management platform with a 39% reduction in hospitalizations for home PD patients receiving care at Baxter Renal Care Services clinics in Colombia.